Desjardins Global Asset Management »

United Therapeutics Corporation shares owned by Desjardins Global Asset Management

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Desjardins Global Asset Management from 13F filings

Historical chart of Desjardins Global Asset Management investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Desjardins Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Desjardins Global Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 7.2k 219.89
2023-09-30 $1.7M 7.3k 225.87
2023-03-31 $1.1M 4.7k 224.04

More positions owned by Desjardins Global Asset Management

Vaneck Vectors Gold Miners Etf Exchange Traded Fund Share (GDX)
Microsoft Corp Common Stock (MSFT)
Ishares Russell 2000 Exchange Traded Fund Share (IWM)
Ishares Core S&p 500 Etf Exchange Traded Fund Share (IVV)
Apple Common Stock (AAPL)
Ishares Msci Emerging Markets Ex China Etf Exchange Traded Fund Share (EMXC)
Cintas Corp Common Stock (CTAS)
Nvidia Corp Common Stock (NVDA)
Zoetis Common Stock (ZTS)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Booking Holdings Common Stock (BKNG)
Ishares Esg Aware Msci Eafe Etf Exchange Traded Fund Share (ESGD)
Invesco Qqq Trust Series 1 Exchange Traded Fund Share (QQQ)
Alphabet Inc A Common Stock (GOOGL)

View all positions for Desjardins Global Asset Management

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
Wellington Management Company
venBio Select Advisor
State Street Corporation
Renaissance Technologies
Geode Capital Management
FMR
LSV Asset Management
AQR Capital Management
Arrowstreet Capital, Limited Partnership
Dimensional Fund Advisors
Pacer Advisors
Hanna Zanoni
Alliancebernstein

View all funds holding United Therapeutics Corporation